APA (7th ed.) Citation

Tarantelli, C., Gaudio, E., Hillmann, P., Spriano, F., Rinaldi, A., Kwee, I., . . . Bertoni, F. (2016). 96 - The novel mTORC1/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas. European Journal of Cancer, 69, S38. https://doi.org/10.1016/S0959-8049(16)32696-X

Chicago Style (17th ed.) Citation

Tarantelli, C., et al. "96 - The Novel MTORC1/2 Inhibitor PQR620 Has in Vitro and in Vivo Activity in Lymphomas." European Journal of Cancer 69 (2016): S38. https://doi.org/10.1016/S0959-8049(16)32696-X.

MLA (9th ed.) Citation

Tarantelli, C., et al. "96 - The Novel MTORC1/2 Inhibitor PQR620 Has in Vitro and in Vivo Activity in Lymphomas." European Journal of Cancer, vol. 69, 2016, p. S38, https://doi.org/10.1016/S0959-8049(16)32696-X.